Showing results (131-140 of 313) with videos related to
Sort By:
Pageof 32
Cancer|June 23, 2005
Significance of myelofibrosis in early chronic-phase, chronic myelogenous leukemia on imatinib mesylate therapyHagop M Kantarjian, Carlos E Bueso-Ramos, Moshe Talpaz, et al.Cancer|December 13, 2006
Phase I/II study of subcutaneous homoharringtonine in patients with chronic myeloid leukemia who have failed prior therapyAlfonso Quintás-Cardama, Hagop Kantarjian, Guillermo Garcia-Manero, et al.Cancer|October 22, 2008
Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survivalGautam Borthakur, Hagop Kantarjian, Xuemei Wang, et al.Cancer Research|December 7, 2007
WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cellsAlessandra Ferrajoli, Stefan Faderl, Quin Van, et al.Cancer|February 8, 2006
Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposalJorge E Cortes, Moshe Talpaz, Susan O'Brien, et al.Cancer|September 16, 2003
Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemiaJorge Cortes, Moshe Talpaz, Susan O'Brien, et al.Cancer|September 13, 2007
PEG-IFN-alpha-2b therapy in BCR-ABL-negative myeloproliferative disorders: final result of a phase 2 studyElias Jabbour, Hagop Kantarjian, Jorge Cortes, et al.Investigational New Drugs|June 3, 2010
Kit inhibitor APcK110 extends survival in an AML xenograft mouse modelStefan Faderl, Carlos Bueso-Ramos, Zhiming Liu, et al.Cancer|October 21, 2010
A phase 1-2 study of a farnesyltransferase inhibitor, tipifarnib, combined with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromeElias Jabbour, Hagop Kantarjian, Farhad Ravandi, et al.Cancer|May 12, 2006
Activity of alemtuzumab in patients with CD52-positive acute leukemiaRaoul Tibes, Michael J Keating, Alessandra Ferrajoli, et al.Pageof 32